Torahito A. Gao, Ryan M. Shih, Justin D. Clubb, Shao-Hsi Hung, Tanya Singh, Laura B. James-Allan, Ga / science - Science Translational Medicine, Volume 18, Issue 839, March 2026.
#pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch
Monday, March 9, 2026, 4:22 am / permalink 20364 / 18 stories in 7 days
Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (17 hrs)
Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival (20 hrs)
FDA approves leucovorin for rare folate disorder despite autism hype (32 hrs)
Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (17 hrs)
Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival (20 hrs)
HORMAD1 emerges as a potential target in triple‑negative breast cancer (45 hrs)
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.